Copyright: ©Author(s) 2026.
World J Clin Cases. May 16, 2026; 14(14): 120574
Published online May 16, 2026. doi: 10.12998/wjcc.v14.i14.120574
Published online May 16, 2026. doi: 10.12998/wjcc.v14.i14.120574
Table 1 Baseline demographics, comorbidities, and laboratory findings stratified by glycated hemoglobin levels in older patients with diabetes mellitus, n (%)
| Variables | Total population | HbA1c < 6.5% | HbA1c 6.5%-8.0% | HbA1c > 8.0% | P value |
| Demographics | |||||
| Female sex | 240 (55.8) | 145 (58.9) | 72 (52.6) | 23 (48.9) | 0.291 |
| Age, years | 81.5 ± 7.3 | 82.5 [76.8-87.0] | 82.0 [75.5-87.5] | 82.0 [78.0-86.0] | 0.870 |
| BMI, kg/m2 | 25.6 [23.4-28.0] | 25.7 [23.5-28.0] | 25.5 [23.4-28.0] | 25.7 [23.5-28.7] | 0.929 |
| Functional status | |||||
| Median Katz index | 0.05 | ||||
| Katz Index - no limitation | 156 (36.4) | 87 (35.5) | 59 (43.1) | 10 (21.3) | |
| Katz Index - mild limitation | 78 (18.2) | 50 (20.4) | 20 (14.6) | 8 (17.0) | |
| Katz Index - severe limitation | 196 (45.5) | 109 (44.1) | 58 (42.3) | 29 (61.7) | |
| CFS | |||||
| Median CFS | 0.003 | ||||
| CFS 1-3 (fit-managing well) | 145 (33.7) | 76 (30.9) | 60 (43.8) | 9 (19.1) | |
| CFS 4-5 (vulnerable-mildly frail) | 84 (19.5) | 57 (23.2) | 20 (14.6) | 7 (14.9) | |
| CFS ≥ 6 (moderate-severe frailty) | 201 (46.7) | 113 (45.9) | 57 (41.6) | 31 (66.0) | |
| CCI | |||||
| Median CCI | 0.193 | ||||
| CCI 1-3 | 7 (1.6) | 4 (1.6) | 3 (2.2) | 0 (0.0) | |
| CCI 4-5 | 132 (30.7) | 80 (32.5) | 44 (32.1) | 8 (17.0) | |
| CCI ≥ 6 | 291 (67.7) | 162 (65.9) | 90 (65.7) | 39 (83.0) | |
| Diabetes-related variables | |||||
| Diabetes duration, years | 13 [11-16] | 13 [11-16] | 13 [10-16.5] | 12 [10-16] | 0.735 |
| HbA1c, % [IQR] | 6.1 [5.5-7.1] | 5.5 [5.1-6.0] | 7.1 [6.9-7.45] | 9.0 [8.8-9.8] | < 0.001 |
| Number of drugs | 8.4 ± 3.2 | 8.0 [6.0-10.0] | 8.0 [6.0-10.0] | 9.0 [7.0-11.0] | 0.314 |
| Living status/care needs | |||||
| Nursing home resident | 33 (7.7) | 19 (7.7) | 9 (6.6) | 5 (10.6) | 0.664 |
| Urinary catheter | 49 (11.4) | 31 (12.6) | 13 (9.5) | 5 (10.6) | 0.646 |
| Bed-ridden patient | 186 (43.3) | 104 (42.3) | 53 (38.7) | 29 (61.7) | 0.020 |
| Outcomes | |||||
| In-hospital mortality | 62 (14.4) | 34 (13.8) | 17 (12.4) | 11 (23.4) | 0.166 |
| Readmission within 3 years | 228 (62.0) | 137 (64.6) | 64 (53.3) | 27 (75.0) | 0.029 |
| 3-year mortality | 202 (54.9) | 128 (63.4) | 54 (26.7) | 20 (55.6) | 0.026 |
| 3-year mortality by sex | |||||
| Male | 85 (23.1) | 53 (58.2) | 22 (39.3) | 10 (55.6) | 0.249 |
| Female | 117 (31.8) | 75 (62.0) | 32 (50.0) | 10 ( 55.6) | |
- Citation: Papakitsou I, Papazachariou A, Filippatos TD. Association of glycated hemoglobin levels with 3-year mortality in hospitalized older adults with diabetes: The role of frailty. World J Clin Cases 2026; 14(14): 120574
- URL: https://www.wjgnet.com/2307-8960/full/v14/i14/120574.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i14.120574